Drugs Made In America Acquisition Corp. confirmed that improper withdrawals from an affiliate's working capital account did not affect its own Trust Account, with approximately $241,292,436 held as of March 6, 2026. The board verified the integrity of the Company's Trust Account following the affiliate's irregularities.
Key takeaways
Affiliate Drugs Made In America Acquisition II Corp. had improper withdrawals from working capital account between September 26, 2025 and December 31, 2025
Company's board confirmed no irregularities extended to its Trust Account
Trust Account balance: approximately $241,292,436 as of March 6, 2026
Initial public offering of affiliate completed on September 26, 2025